Matthew A. Whitman

749 total citations
11 papers, 256 citations indexed

About

Matthew A. Whitman is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Matthew A. Whitman has authored 11 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in Matthew A. Whitman's work include Ubiquitin and proteasome pathways (3 papers), Cancer Cells and Metastasis (3 papers) and Bone Tissue Engineering Materials (2 papers). Matthew A. Whitman is often cited by papers focused on Ubiquitin and proteasome pathways (3 papers), Cancer Cells and Metastasis (3 papers) and Bone Tissue Engineering Materials (2 papers). Matthew A. Whitman collaborates with scholars based in United States, Switzerland and Israel. Matthew A. Whitman's co-authors include Oliver Jonas, Steven P. Balk, Sen Chen, Seiji Arai, Eva Corey, Lara A. Estroff, Claudia Fischbach, David Kilburn, Michael J. Cima and Elmar Bucher and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biomaterials and Cancer Research.

In The Last Decade

Matthew A. Whitman

10 papers receiving 254 citations

Peers

Countries citing papers authored by Matthew A. Whitman

Since Specialization

Citations

This map shows the geographic impact of Matthew A. Whitman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew A. Whitman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew A. Whitman more than expected).

Fields of papers citing papers by Matthew A. Whitman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew A. Whitman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew A. Whitman. The network helps show where Matthew A. Whitman may publish in the future.

Co-authorship network of co-authors of Matthew A. Whitman

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew A. Whitman. A scholar is included among the top collaborators of Matthew A. Whitman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew A. Whitman. Matthew A. Whitman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Mineralized bone matrix attenuates breast cancer cell malignancy by altering MSC mechanoregulation 2025 ·Biomaterials ·(unknown), (unknown), Matthew A. Whitman, (unknown), (unknown), Andrew Miller, Lara A. Estroff, Claudia Fischbach	0
2	Bone mineral density affects tumor growth by shaping microenvironmental heterogeneity 2024 ·Biomaterials ·Matthew A. Whitman, Madhav Mantri, E. Spanos, Lara A. Estroff, Iwijn De Vlaminck, Claudia Fischbach	5
3	Bone-matrix mineralization dampens integrin-mediated mechanosignalling and metastatic progression in breast cancer 2023 ·Nature Biomedical Engineering ·Siyoung Choi, Matthew A. Whitman, Lara A. Estroff, (unknown), Aaron E. Chiou, Joseph E. Druso, Akanksha Verma, (unknown), (unknown), Matthew J. Paszek, Olivier Elemento, Lara A. Estroff, Claudia Fischbach	26
4	Plk1 Inhibitors and Abiraterone Synergistically Disrupt Mitosis and Kill Cancer Cells of Disparate Origin Independently of Androgen Receptor Signaling 2022 ·Cancer Research ·Jesse C. Patterson, Andreas Varkaris, Peter J.P. Croucher, Maya Ridinger, Susan L. Dalrymple, Mannan Nouri, Fang Xie, Shohreh Varmeh, Oliver Jonas, Matthew A. Whitman, (unknown), (unknown), (unknown), Jun Luo, John T. Isaacs, Mark G. Erlander, David J. Einstein, Steven P. Balk, Michael B. Yaffe	12
5	REV1 inhibitor JH-RE-06 enhances tumor cell response to chemotherapy by triggering senescence hallmarks 2020 ·Proceedings of the National Academy of Sciences ·Nimrat Chatterjee, Matthew A. Whitman, Cynthia Harris, (unknown), Oliver Jonas, Evan C. Lien, Alba Luengo, Matthew G. Vander Heiden, Jiyong Hong, Pei Zhou, Michael T. Hemann, Graham C. Walker	32
6	VISAGE Reveals a Targetable Mitotic Spindle Vulnerability in Cancer Cells 2019 ·Cell Systems ·Jesse C. Patterson, Brian A. Joughin, A.E. Prota, Tobias Mühlethaler, Oliver Jonas, Matthew A. Whitman, Shohreh Varmeh, Sen Chen, Steven P. Balk, Michel O. Steinmetz, Douglas A. Lauffenburger, Michael B. Yaffe	20
7	Hydroxyapatite mineral enhances malignant potential in a tissue-engineered model of ductal carcinoma in situ (DCIS) 2019 ·Biomaterials ·Frank He, Nora L. Springer, Matthew A. Whitman, (unknown), Yeon‐Kyung Lee, Sunish Mohanan, (unknown), Aaron E. Chiou, Bryant S. Blank, Neil M. Iyengar, Patrick G. Morris, Maxine S. Jochelson, Clifford A. Hudis, Pragya Shah, Jennie A. M. R. Kunitake, Lara A. Estroff, Jan Lammerding, Claudia Fischbach	22
8	Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination with BCLXL/BCL2 Inhibitors Drive Prostate Cancer Apoptosis 2018 ·Clinical Cancer Research ·Seiji Arai, Oliver Jonas, Matthew A. Whitman, Eva Corey, Steven P. Balk, Sen Chen	50
9	Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes 2018 ·Cell Systems ·Spencer S. Watson, Mark Dane, Koei Chin, Zuzana Tatárová, Moqing Liu, Tiera Liby, Wallace Thompson, Rebecca Smith, Michel Nederlof, Elmar Bucher, David Kilburn, Matthew A. Whitman, Damir Sudar, Gordon B. Mills, Laura M. Heiser, Oliver Jonas, Joe W. Gray, James E. Korkola	50
10	Synergistic interactions with PI3K inhibition that induce apoptosis 2017 ·eLife ·Yaara Zwang, Oliver Jonas, (unknown), Mikael L. Rinne, John G. Doench, Federica Piccioni, Li Tan, Hai‐Tsang Huang, Jinhua Wang, (unknown), Joyce T. O’Connell, Patrick Bhola, Mihir B. Doshi, Matthew A. Whitman, Michael J. Cima, Anthony Letai, David E. Root, Róbert Langer, Nathanael S. Gray, William C. Hahn	21
11	Parallel In Vivo Assessment of Drug Phenotypes at Various Time Points during Systemic BRAF Inhibition Reveals Tumor Adaptation and Altered Treatment Vulnerabilities 2016 ·Clinical Cancer Research ·Oliver Jonas, Madeleine J. Oudin, Tatsiana Kosciuk, Matthew A. Whitman, Frank B. Gertler, Michael J. Cima, Keith T. Flaherty, Róbert Langer	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact